Adam Burgess

Adam Burgess is a seasoned quality assurance professional with extensive experience in the pharmaceutical industry. Currently serving as Vice President and Head of Quality at Kiniksa Pharmaceuticals since December 2020, Adam has held significant roles including Executive Director of Quality Assurance and Executive Director, Head of Quality (Qualified Person) for the drug Rilonacept. Prior positions include Director of Quality Assurance at Oval Medical Technologies, Quality Director at Ethypharm, and various quality-focused roles at Aesica Pharmaceuticals Ltd, MHRA, Martindale Pharma, and GlaxoSmithKline. Adam's career highlights include managing quality assurance for investigational and licensed medicinal products, driving quality culture across organizations, and overseeing defect reporting and resolution strategies. Adam holds a BSc in Chemistry from the University of Reading.